ATE174967T1 - Monoklonale antikörper gegen glykoprotein p - Google Patents

Monoklonale antikörper gegen glykoprotein p

Info

Publication number
ATE174967T1
ATE174967T1 AT93912996T AT93912996T ATE174967T1 AT E174967 T1 ATE174967 T1 AT E174967T1 AT 93912996 T AT93912996 T AT 93912996T AT 93912996 T AT93912996 T AT 93912996T AT E174967 T1 ATE174967 T1 AT E174967T1
Authority
AT
Austria
Prior art keywords
pct
glycoprotein
date dec
monoclonal antibodies
antibodies against
Prior art date
Application number
AT93912996T
Other languages
English (en)
Inventor
Maurizio Cianfriglia
Original Assignee
Ist Superiore Sanita
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Superiore Sanita filed Critical Ist Superiore Sanita
Application granted granted Critical
Publication of ATE174967T1 publication Critical patent/ATE174967T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT93912996T 1992-06-17 1993-06-16 Monoklonale antikörper gegen glykoprotein p ATE174967T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920457A IT1257893B (it) 1992-06-17 1992-06-17 Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteina umana.

Publications (1)

Publication Number Publication Date
ATE174967T1 true ATE174967T1 (de) 1999-01-15

Family

ID=11401066

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93912996T ATE174967T1 (de) 1992-06-17 1993-06-16 Monoklonale antikörper gegen glykoprotein p

Country Status (20)

Country Link
US (1) US5766946A (de)
EP (1) EP0648276B1 (de)
JP (1) JPH08501925A (de)
KR (1) KR100301189B1 (de)
AT (1) ATE174967T1 (de)
AU (1) AU672798B2 (de)
CA (1) CA2134752A1 (de)
CZ (1) CZ284847B6 (de)
DE (1) DE69322783T2 (de)
DK (1) DK0648276T3 (de)
ES (1) ES2130271T3 (de)
FI (1) FI945865A (de)
GR (1) GR3029773T3 (de)
HU (1) HU216877B (de)
IT (1) IT1257893B (de)
NO (1) NO944887D0 (de)
NZ (1) NZ253139A (de)
RU (1) RU2126836C1 (de)
SK (1) SK280272B6 (de)
WO (1) WO1993025700A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994088A (en) * 1991-03-08 1999-11-30 Board Of Trustees Of The University Of Illinois Methods and reagents for preparing and using immunological agents specific for P-glycoprotein
EP0669941A1 (de) * 1992-11-02 1995-09-06 NICOLAU, Yves Claude Verfahren zur Verminderung der Multidrogenresistenz in Zellen und Geweben.
US5686578A (en) * 1994-08-05 1997-11-11 Immunomedics, Inc. Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
WO1997046254A2 (en) * 1996-06-05 1997-12-11 Eugene Mechetner Reagents and methods for inhibiting cytokine release by blood cells
AU5799199A (en) * 1998-09-04 2000-03-27 Immunomedics Inc. Diagnosis of multidrug resistance in cancer and infectious lesions
AU2001236588A1 (en) * 2000-01-31 2001-08-07 The Procter And Gamble Company Antibodies to the staphylococcal multidrug resistance (smr) protein
EP3333182A1 (de) 2000-06-05 2018-06-13 The Brigham and Women's Hospital, Inc. Gen zur codierung eines multidrug-resistenten humanen p-glycoprotein-homologs auf chromosom 7p15-21 und verwendungen davon
EP1223534A1 (de) * 2001-01-14 2002-07-17 Katz, Emil Peptide, welche für spezifische Polypeptide repräsentativ sind, gegen diese Peptide gerichtete Antikörper, sowie Methoden, Systeme und Kits zur Herstellung und Verwendung dieser Peptide und Antikörper
US8663650B2 (en) 2003-02-21 2014-03-04 Ac Immune Sa Methods and compositions comprising supramolecular constructs
US7294701B2 (en) * 2003-04-02 2007-11-13 Technion Research & Development Foundation Ltd. Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
FR2857875A1 (fr) * 2003-07-25 2005-01-28 Univ Reims Champagne Ardenne Vaccin therapeutique cible contre la p-glycoproteine 170 pour inhiber la resistance multidrogues dans le traitement des cancers
US7807171B2 (en) 2003-07-25 2010-10-05 Ac Immune Sa Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
US20060068426A1 (en) * 2004-08-20 2006-03-30 Tam James P Cyclic peptides and antibodies thereof
PL2772535T3 (pl) 2006-05-31 2022-09-05 Children's Medical Center Corporation Mezenchymalne komórki macierzyste ABC5 dodatnie jako immunomodulatory
FR2906533B1 (fr) * 2006-09-28 2013-02-22 Pf Medicament Procede de generation d'anticorps actifs contre un antigene de resistance,anticorps obtenus par ledit procede et leurs utilisations
JP5889527B2 (ja) 2007-04-12 2016-03-22 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． 癌療法のためのａｂｃｂ５標的化
EP3527220A1 (de) 2010-08-12 2019-08-21 AC Immune S.A. Manipulation von impfstoffen
US9687447B2 (en) 2010-10-26 2017-06-27 Ac Immune S.A. Method for preparing liposome-based constructs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206352A (en) * 1986-03-28 1993-04-27 Board Of Trustees Of The University Of Illinois Compositions for clones containing DNA sequences associated with multidrug resistance in human cells
US5434075A (en) * 1992-03-20 1995-07-18 Board Of Trustees Of The University Of Illinois Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
US5773280A (en) * 1992-03-20 1998-06-30 The Board Of Trustees Of The University Of Illinois Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
EP0569141A3 (de) * 1992-04-14 1994-10-26 Hybritech Inc Methode zur Hemmung des Wachstums von multidrugresistenten Tumoren durch Antikörper.
US5369009A (en) * 1992-04-17 1994-11-29 Dana Farber Cancer Institute Antibodies for P-glycoprotein encoded by the mdr1 gene and uses thereof

Also Published As

Publication number Publication date
FI945865A (fi) 1995-02-08
NO944887L (no) 1994-12-16
HU9403614D0 (en) 1995-02-28
SK155494A3 (en) 1995-07-11
CZ318194A3 (en) 1995-07-12
GR3029773T3 (en) 1999-06-30
SK280272B6 (sk) 1999-10-08
US5766946A (en) 1998-06-16
CZ284847B6 (cs) 1999-03-17
ES2130271T3 (es) 1999-07-01
RU94046414A (ru) 1996-11-10
DE69322783T2 (de) 1999-06-10
HUT70469A (en) 1995-10-30
RU2126836C1 (ru) 1999-02-27
DE69322783D1 (de) 1999-02-04
KR100301189B1 (ko) 2001-10-22
CA2134752A1 (en) 1993-12-23
HU216877B (hu) 1999-09-28
ITRM920457A0 (it) 1992-06-17
NO944887D0 (no) 1994-12-16
AU4326693A (en) 1994-01-04
ITRM920457A1 (it) 1993-12-17
EP0648276B1 (de) 1998-12-23
EP0648276A1 (de) 1995-04-19
IT1257893B (it) 1996-02-16
AU672798B2 (en) 1996-10-17
NZ253139A (en) 1996-09-25
WO1993025700A1 (en) 1993-12-23
DK0648276T3 (da) 1999-08-23
JPH08501925A (ja) 1996-03-05
FI945865A0 (fi) 1994-12-13

Similar Documents

Publication Publication Date Title
ATE174967T1 (de) Monoklonale antikörper gegen glykoprotein p
NO962346L (no) Humaniserte antistoffer og anvendelser derav
RS51309B (sr) Humana monoklonalna antitela za ctla-4
CA2451680A1 (en) Human dr4 antibodies and uses thereof
DE59508864D1 (de) MONOKLONALER ANTIKÖRPER GEGEN CD44v6
DK0523395T3 (da) Seroreaktive områder på proteinerne E1 og E2 i HPV 16
ATE146528T1 (de) Kleinzelliger lungenkarzinom-spezifischer antikörper und antigenen
DE69629688D1 (de) Chemoattraktion-auslösender faktor aus lymphozyten und dessen verwendungen
ATE410514T1 (de) Calciumbindende rekombinante antikörper gegen protein c
DK0547200T3 (da) Rekombinante antistoffer på overfladen af E. coli
TR200001265T2 (tr) Vasp' a karşı antikorlar, bunların hazırlanması için hibridoma hücreleri.
DE3580382D1 (de) Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren.
ATE180512T1 (de) Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik
CA2137280A1 (fr) Clonage du gene codant pour la proteine gp28.5 de toxoplasma gondii; fragments peptidiques de cette proteine et leurs applications
ATE122895T1 (de) Monoklonale antikörper gegen den interleukin 2- rezeptor.
ATE221388T1 (de) Zusammensetzungen die gemischte transferrine als wirkstoff für induktion von immunotoleranz gegen antigen enthalten
ATE121422T1 (de) Neue antikoagulatorisch wirksame peptide.
ATE184315T1 (de) Neuartiges endothelzell-molekül, das die bindung von lymphozyten im menschen vermittelt
CA2148689A1 (en) Treatment of infertility and enhancement of fertilization capacity in mammalian males
ATE328088T1 (de) Transketolase-verwandtes protein
EP0554670A3 (en) Specific antibodies against activated platelets, their production and applications in diagnostics and therapeutics
RU94026276A (ru) Рецепторы интерлейкина-12 и антител

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee